TIMMONS AND COMPANY, INC. for TEVA PHARMACEUTICALS USA INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 515 - A bill to amend title 35, United States Code, to provide for patent reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J BATES | — |
| MICHELLE BRIGHT | — |
| ERIN GRAEFE DORTON | — |
| BRYCE L HARLOW | — |
| CHARLES JONES New | Legislative Asst - Office of Senator Tom Carper |
| GINGER LOPER | — |
| MARTIN PAONE | — |
| WILLIAM E TIMMONS | — |
Health Issues HCR
H.R. 1427 - To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes. S. 726 - A bill to amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J BATES | — |
| MICHELLE BRIGHT | — |
| ERIN GRAEFE DORTON | — |
| BRYCE L HARLOW | — |
| CHARLES JONES New | Legislative Asst - Office of Senator Tom Carper |
| GINGER LOPER | — |
| MARTIN PAONE | — |
| WILLIAM E TIMMONS | — |
Labor Issues/Antitrust/Workplace LBR
H.R. 1706 - To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369 - A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J BATES | — |
| MICHELLE BRIGHT | — |
| ERIN GRAEFE DORTON | — |
| BRYCE L HARLOW | — |
| CHARLES JONES New | Legislative Asst. - Office of Senator Tom Carper |
| GINGER LOPER | — |
| MARTIN PAONE | — |
| WILLIAM E TIMMONS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.